The senate is preparing to vote on a Continuing Resolution that will fund the federal government from Oct. 1, 2012, through March 31, 2013, by limiting all agencies to monies received in fiscal year 2012. As reasonable as that sounds, the resolution could have a disproportionately large affect on the FDA, because it omits language that would have allowed the FDA to collect user fees provided for in FDASIA for 2013.